Parkinson Diseasealpha-SynucleinAntiparkinson AgentsParkinsonian DisordersGlucosylceramidaseLevodopaLewy BodiesParkinson Disease, SecondarySubstantia NigraDeep Brain Stimulation1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDopamineDopaminergic NeuronsSubthalamic NucleusLewy Body DiseaseMultiple System AtrophyGait Disorders, NeurologicOxidopamineMPTP PoisoningPostural BalanceDance TherapyNeurodegenerative DiseasesPutamenUbiquitin-Protein LigasesSupranuclear Palsy, ProgressiveEssential TremorPedunculopontine Tegmental NucleusNeuronsGaitBrainGaucher DiseaseREM Sleep Behavior DisorderTyrosine 3-MonooxygenasePergolidebeta-SynucleinHypokinesiaOncogene ProteinsNerve DegenerationCorpus StriatumGlobus PallidusDementiaCarbidopaManebGenetic Predisposition to DiseaseAge of OnsetMutationMovement DisordersMesencephalonMitochondriaSynucleins1-Methyl-4-phenylpyridiniumNeuropsychological TestsSeverity of Illness IndexNeuroprotective AgentsTropanesDopamine Plasma Membrane Transport ProteinsCase-Control StudiesSleep Arousal DisordersPositron-Emission TomographyApathyDisease Models, AnimalBenzothiazolesPrimary DysautonomiasDyskinesiasPostmortem ChangesOlfaction DisordersAlzheimer Diseasetau ProteinsAutophagyManganese PoisoningGenetic TestingDyskinesia, Drug-InducedPure Autonomic FailureRotenoneDopamine AgentsCognition DisordersParaquatDopamine AgonistsGenome-Wide Association StudyNeurologic ExaminationPemolineSelenoprotein W3,4-Dihydroxyphenylacetic AcidReality TherapySweat Gland DiseasesNerve Tissue ProteinsAdrenergic AgentsBasal GangliaChromogranin BAccidental FallsPolymorphism, Single NucleotideParkinson Disease, PostencephaliticIntroversion (Psychology)Oxidative StressMotor SkillsPenetranceStereotaxic TechniquesVesicular Monoamine Transport ProteinsImpulse Control DisordersDreams